Keyphrases
Induced Pluripotent Stem Cells (iPSCs)
66%
Advanced Fibrosis
64%
Transient Elastography
62%
Liver Transplantation
42%
Liver Fibrosis
41%
Risk Factors
40%
Single Center
36%
Functional Correction
33%
Unresectable Liver Metastases
33%
Xanthogranulomatous Cholecystitis
33%
Non-invasive Scoring System
33%
Neutrophils
33%
Metabolic-associated Fatty Liver Disease (MAFLD)
33%
Myocardial Perfusion Imaging
33%
Post-liver Transplant
33%
Steatosis
33%
Oxidase
33%
United States
33%
CD34+ Cells
33%
X-linked Chronic Granulomatous Disease (X-CGD)
33%
Morphometry
33%
Prevalence Factors
33%
Transgene-free
33%
Cholangiocarcinoma
33%
Safe Harbor
33%
Peripheral Blood
33%
Hepatitis C
33%
Sustained Virological Response
33%
Imaging Findings
33%
Zinc Finger nuclease
33%
Adolescent Population
33%
Adverse Cardiac Events
33%
Direct-acting Antivirals
33%
Positron Emission Tomography
33%
Yttrium-90 Radioembolization
33%
Fibrosis Regression
33%
Non-alcoholic Fatty Liver Disease (NAFLD)
23%
Alcoholic Liver Disease
16%
Autoimmune Liver Disease
16%
Liver Cirrhosis
16%
Viral Hepatitis
16%
Fatty Liver Disease
16%
Liver Cancer
16%
LoxP
16%
Steatosis Grade
16%
Gp91phox
16%
Reactive Oxygen Species Production
16%
Partial Response
16%
Controlled Attenuation Parameter
16%
Liver Transplant Recipients
15%
Medicine and Dentistry
Fibrosis
100%
Transient Elastography
69%
Fatty Liver
41%
Liver Fibrosis
38%
Non-Alcoholic Fatty Liver Disease
35%
Liver Cancer
33%
Morphometrics
33%
Positron Emission Tomography
33%
Yttrium 90
33%
Hepatitis Virus
33%
Cholangiocarcinoma
33%
Autoimmune Liver Disease
33%
Myocardial Perfusion Imaging
33%
Steatosis
33%
Cirrhosis
33%
Major Adverse Cardiac Event
33%
Alcohol-Related Liver Disease
33%
Scoring System
33%
Antivirus Agent
33%
Cholangitis
33%
Radioembolization
33%
Liver Graft
33%
Liver Transplantation
33%
Prevalence
33%
Liver Metastasis
33%
Hepatitis C
33%
Liver Cirrhosis
24%
Cancer
17%
Adolescent
16%
Nonalcoholic Fatty Liver
14%
Cholecystitis
12%
Body Mass Index
11%
Liver Biopsy
11%
Biopsy
9%
Disease
9%
Coronary Circulation
8%
Antiviral Therapy
7%
Heart Left Ventricle Ejection Fraction
6%
Odds Ratio
6%
Clinician
6%
Alanine Aminotransferase
5%
Onset Age
5%
Linear Regression Analysis
5%
Insulin Resistance
5%
Systolic Blood Pressure
5%
Chronic Liver Disease
5%
Steatohepatitis
5%
Population Research
5%
Decompensated Liver Cirrhosis
5%
